Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Pinter, A."'
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36:228-236
Plaque psoriasis is a common, chronic and relapsing inflammatory skin disease clinically characterized by erythema and scaling desquamation. As over 90% of psoriasis patients benefit from topical therapies, local treatments continue to play an eminen
Autor:
Lorenz Balcar, Georg Semmler, Katharina Pomej, Michael Trauner, B Scheiner, Thomas Reiberger, Mattias Mandorfer, Christian Müller, Tobias Meischl, Matthias Pinter
Publikováno v:
Journal of Hepatocellular Carcinoma
Katharina Pomej,1,2,* Lorenz Balcar,1â 3,* Bernhard Scheiner,1â 4 Georg Semmler,1,3 Tobias Meischl,1,2 Mattias Mandorfer,1,3,4 Thomas Reiberger,1,3â 5 Christian Müller,1,2 Michael Trauner,1,4 Matthias Pinter1,2,4 1Division o
Autor:
Thomas Reiberger, Peter Quehenberger, Ton Lisman, Matthias Pinter, Teresa Binter, Katharina Pomej, Jeannette Becker, Lorenz Balcar, Michael Trauner, Georg Semmler, Lukas Hartl, Bernhard Scheiner, Benedikt Simbrunner, David Bauer, Mattias Mandorfer
Publikováno v:
Liver International
Liver International, 41(9), 2159-2170. Wiley
Liver International, 41(9), 2159-2170. Wiley
Background & Aims While direct oral anticoagulants (DOACs) are increasingly used in patients with liver disease, safety data especially in advanced chronic liver disease (ACLD) are limited. Methods Liver disease patients receiving DOAC treatment (ACL
Autor:
Steven M. Horwitz, Jan Walewski, David C. Fisher, Meredith Little, Judith Trotman, Rudolf Stadler, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Reinhard Dummer, Kerry Taylor, Larisa J. Geskin, Madeleine Duvic, Oliver Bechter, Herbert Eradat, Sean Whittaker, José Antonio Sanches, Lauren C. Pinter-Brown, Stéphane Dalle, Julia Scarisbrick, Michael Weichenthal, H. Miles Prince, Veronica Bunn, Julie Lisano, Pietro Quaglino, Oleg E. Akilov, Youn H. Kim
The primary analysis of the phase 3 ALCANZA trial showed significantly improved objective responses lasting ≥4 months (ORR4; primary endpoint) and progression-free survival (PFS) with brentuximab vedotin vs physician's choice (methotrexate or bexar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d40397afcea6ca7a1f9be3a06d435ee
https://lirias.kuleuven.be/handle/123456789/681151
https://lirias.kuleuven.be/handle/123456789/681151
Autor:
Aline Lopes Chagas, Gabriel Aballay Soteras, Margarita Sala, Adolfo Gallego, Yolanda Sánchez-Torrijos, Marcus-Alexander Wörns, Carlos Huertas, Leonardo Gomes da Fonseca, Carlos Rodríguez de Lope, Margarita Anders, M. Varela, Manuel Hernández-Guerra, Rogerio Alves, Maria Reig, Sonia Pascual, Marco Sanduzzi-Zamparelli, Tania Hernáez, Lorenza Rimassa, Mário Reis Álvares-da-Silva, Alessandro Granito, Juan Arenas, Beatriz Minguez, Cassia Leal, Ana Matilla, Jordi Bruix, Morten Ladekarl, Alberto Lué, Alex Vianey Callado França, Christie Perelló, Rodolfo Sacco, José Luis Lledó, Álvaro Díaz-González, Matthias Pinter, Juan Ignacio Marín, Gustavo Pereira, Susanna Coll, Giovan Giuseppe Di Costanzo, Massimo Iavarone, Ángela Rojas, Federico Piñero, Mercedes Vergara, Edoardo G. Giannini, Jean-Charles Nault, Mar Lozano, Bruno Sangro, Ignacio Garcia Juarez, Vivianne Mello, Josemaría Menéndez, Manuel Delgado
Publikováno v:
Díaz-González, Á, Sanduzzi-Zamparelli, M, da Fonseca, L G, Di Costanzo, G G, Alves, R, Iavarone, M, Leal, C, Sacco, R, Matilla, A M, Hernández-Guerra, M, Aballay Soteras, G, Wörns, M A, Pinter, M, Varela, M, Ladekarl, M, Chagas, A L, Mínguez, B, Arenas, J I, Granito, A, Sánchez-Torrijos, Y, Rojas, Á, Rodríguez de Lope, C, Alvares-da-Silva, M R, Pascual, S, Rimassa, L, Lledó, J L, Huertas, C, Sangro, B, Giannini, E G, Delgado, M, Vergara, M, Perelló, C, Lue, A, Sala, M, Gallego, A, Coll, S, Hernáez, T, Piñero, F, Pereira, G, França, A, Marín, J, Anders, M, Mello, V, Lozano, M, Nault, J C, Menéndez, J, García Juárez, I, Bruix, J & Reig, M 2020, ' International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis ', Liver International, vol. 40, no. 6, pp. 1467-1476 . https://doi.org/10.1111/liv.14436
LIVER INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Díaz-González, Á, Sanduzzi-Zamparelli, M, Gomes da Fonseca, L L, Di Costanzo, G G, Alves, R, Iavarone, M, Leal, C, Sacco, R, Matilla, A M, Hernández-Guerra, M, Aballay Soteras, G, Wörns, M-A, Pinter, M, Varela, M, Ladekarl, M, Chagas, A L, Mínguez, B, Arenas, J I, Granito, A, Sánchez-Torrijos, Y, Rojas, Á, Rodríguez de Lope, C, Alvares-da-Silva, M R, Pascual, S, Rimassa, L, Lledó, J L, Huertas, C, Sangro, B, Giannini, E G, Delgado, M, Vergara, M, Perelló, C, Lue, A, Sala, M, Gallego, A, Coll, S, Hernáez, T, Piñero, F, Pereira, G, França, A, Marín, J, Anders, M, Mello, V, Lozano, M, Nault, J C, Menéndez, J, García Juárez, I, Bruix, J & Reig, M 2020, ' International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis ', Liver International, vol. 40, no. 6, pp. 1467-1476 . https://doi.org/10.1111/liv.14436
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Liver International
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
LIVER INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Díaz-González, Á, Sanduzzi-Zamparelli, M, Gomes da Fonseca, L L, Di Costanzo, G G, Alves, R, Iavarone, M, Leal, C, Sacco, R, Matilla, A M, Hernández-Guerra, M, Aballay Soteras, G, Wörns, M-A, Pinter, M, Varela, M, Ladekarl, M, Chagas, A L, Mínguez, B, Arenas, J I, Granito, A, Sánchez-Torrijos, Y, Rojas, Á, Rodríguez de Lope, C, Alvares-da-Silva, M R, Pascual, S, Rimassa, L, Lledó, J L, Huertas, C, Sangro, B, Giannini, E G, Delgado, M, Vergara, M, Perelló, C, Lue, A, Sala, M, Gallego, A, Coll, S, Hernáez, T, Piñero, F, Pereira, G, França, A, Marín, J, Anders, M, Mello, V, Lozano, M, Nault, J C, Menéndez, J, García Juárez, I, Bruix, J & Reig, M 2020, ' International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis ', Liver International, vol. 40, no. 6, pp. 1467-1476 . https://doi.org/10.1111/liv.14436
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Liver International
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Background & Aims: Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to patient exclusion from clinical trials. Thus, we aimed to evaluate the rate, prevalence, tol
Autor:
van Straalen, Kelsey R., Tzellos, Thrasyvoulos, Guillem, Phillipe, Benhadou, Farida, Cuenca-Barrales, Carlos, Daxhelet, Mathilde, Daoud, Mathieu, Efthymiou, Ourania, Giamarellos-Bourboulis, Evangelos J., Jemec, Gregor B.E., Katoulis, Alexandros C., Koenig, Anke, Lazaridou, Elizabeth, Marzano, Angelo V., Matusiak, Łucas, Molina-Leyva, Alejandro, Moltrasio, Chiara, Pinter, Andreas, Potenza, Concetta, Romaní, Jorge, Saunte, Ditte M., Skroza, Nevena, Stergianou, Dimitra, Szepietowski, Jacek, Trigoni, Anastasia, Vilarrasa-Rull, Eva, van der Zee, Hessel H., Universitat Autònoma de Barcelona
Publikováno v:
van Straalen, K R, Tzellos, T, Guillem, P, Benhadou, F, Cuenca-Barrales, C, Daxhelet, M, Daoud, M, Efthymiou, O, Giamarellos-Bourboulis, E J, Jemec, G B E, Katoulis, A C, Koenig, A, Lazaridou, E, Marzano, A V, Matusiak, Ł, Molina-Leyva, A, Moltrasio, C, Pinter, A, Potenza, C, Romaní, J, Saunte, D M, Skroza, N, Stergianou, D, Szepietowski, J, Trigoni, A, Vilarrasa, E & van der Zee, H H 2021, ' The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa : Results of a prospective European cohort study ', Journal of the American Academy of Dermatology, vol. 85, no. 2, pp. 369-378 . https://doi.org/10.1016/j.jaad.2020.12.089
Journal of the American Academy of Dermatology
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of the American Academy of Dermatology, 85(2), 369-378. Mosby Inc.
Journal of the American Academy of Dermatology
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of the American Academy of Dermatology, 85(2), 369-378. Mosby Inc.
Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current Hidradenitis Suppurativa (HS) guidelines. However, evidence for their efficacy is drawn from small studies, often without validated ou
Autor:
Meredith Little, Lisa Brown, José Antonio Sanches, Pietro Quaglino, J. Scarisbrick, Oliver Bechter, Kerry Taylor, David E. Fisher, Matthew Onsum, M. Corinna Palanca-Wessels, Veronica Bunn, Pascal Wolter, Steven M. Horwitz, Jan Walewski, Judith Trotman, Madeleine Duvic, Rudolf Stadler, Lauren C. Pinter-Brown, Herbert Eradat, Reinhard Dummer, Pier Luigi Zinzani, Marise McNeeley, Sean Whittaker, Alejandro A. Gru, Pablo L. Ortiz-Romero, Julie Lisano, H. Miles Prince, Michael Weichenthal, Youn H. Kim, William L. Trepicchio, Oleg E. Akilov
INTRODUCTION: Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, can lead to disfiguring lesions, debilitating pruritus and frequent skin infections. This study assessed response to brentuximab vedotin in patients with MF in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3b61df0e6864ee0a19d3ccb015c2ca
https://lirias.kuleuven.be/handle/123456789/674933
https://lirias.kuleuven.be/handle/123456789/674933
Autor:
Matthias Pinter, Pietro Lampertico, Ainhoa Fernandez Yunquera, Gabriel Aballay Soteras, Miguel Fraile-López, Tommy Ivanics, Maria Reig, Massimo Iavarone, Álvaro Díaz-González, Maria Varela, Lucia Cesarini, Vincenzo Mazzaferro, Gerda Elisabeth Villadsen, Federica Invernizzi, Matteo Angelo Manini, Marcus A. Wörns, Maria Jose Blanco Rodríguez, Mario Romero Cristóbal, Helene Regnault, Giovanni Giuseppe Di Costanzo, Jordi Bruix, Sherrie Bhoori, Peter Daechul Yoon, Arndt Weinmann, Marco Sanduzzi-Zamparelli, Luigia Scudeller, Maria Francesca Donato, Gonzalo Sapisochin, Giuliana Amaddeo, Stefano Mazza, Carolin Czauderna, Gonzalo Crespo, Claudio Zavaglia, Massimo De Giorgio, Margarita Anders, María Luisa González-Diéguez, Rebecca Prince, R. Tortora, Federico Piñero
Publikováno v:
Iavarone, M, Invernizzi, F, Ivanics, T, Mazza, S, Zavaglia, C, Sanduzzi-Zamparelli, M, Fraile-López, M, Czauderna, C, Di Costanzo, G, Bhoori, S, Pinter, M, Manini, M A, Amaddeo, G, Yunquera, A F, Piñero, F, Blanco Rodríguez, M J, Anders, M, Aballay Soteras, G, Villadsen, G E, Yoon, P D, Cesarini, L, Díaz-González, Á, González-Diéguez, M L, Tortora, R, Weinmann, A, Mazzaferro, V, Romero Cristóbal, M, Crespo, G, Regnault, H, De Giorgio, M, Varela, M, Prince, R, Scudeller, L, Donato, M F, Wörns, M A, Bruix, J, Sapisochin, G, Lampertico, P & Reig, M 2021, ' Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation : A Retrospective Study ', Liver Transplantation, vol. 27, no. 12, pp. 1767-1778 . https://doi.org/10.1002/lt.26264
Background and aim Safety of regorafenib in hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been recently demonstrated. We aimed to assess the survival benefit of regorafenib compared to best supportive care (BSC) in LT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0597611aee19dfbc84eb5123deec08
https://pure.au.dk/portal/da/publications/regorafenib-efficacy-after-sorafenib-in-patients-with-recurrent-hepatocellular-carcinoma-after-liver-transplantation(477d1d48-a195-4f99-8a43-edf900941e54).html
https://pure.au.dk/portal/da/publications/regorafenib-efficacy-after-sorafenib-in-patients-with-recurrent-hepatocellular-carcinoma-after-liver-transplantation(477d1d48-a195-4f99-8a43-edf900941e54).html
Publikováno v:
Gut
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a large number of studies are currently investigating ICBs in patients with hepatocellular carcinoma (HCC), alone or in combination with other treatments. Both nivo
Autor:
Bastian Schilling, Thomas Haalck, Sebastian Haferkamp, Jochen Utikal, Patrick Terheyden, Mareike Alter, Andreas Pinter, Ingrid H. Wolf, Michael Max Sachse, Dirk Debus
Publikováno v:
Advances in Therapy. 37:3619-3629
Cutaneous melanoma is one of the most aggressive forms of skin neoplasms and represents a major cause of neoplastic or cancer death in Europe. Without adequate therapy, the 5-year survival rate is 15% when the disease metastasizes to distant organs.